Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion type Assertion NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_head.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion description "[When studying the relations between the most important clinicopathologic features of breast cancer and the mRNA expression level of both MBDs, we found that oestrogen receptor (OR)-positive breast cancer specimens contained higher levels of MeCP2 mRNA than did OR-negative cancers (P=0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion evidence source_evidence_literature NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion SIO_000772 14612906 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion wasDerivedFrom befree-20140225 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.
- NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_assertion wasGeneratedBy ECO_0000203 NP855002.RASfD9g_vVmOs6fqts4fAl_KtxiKmgacLyLrgN4zX2HJY130_provenance.